-
Emergent BioSolutions could invest up to $120M in Baltimore, CFO says - Baltimore Business Journal
-
Christie Administration Approves $60 Million to Grow Tech/Bio Tech Industry in New Jersey
-
Bethesda's Northwest Biotherapeutics, developer of personalized immune therapies for solid tumor cancers raises $27,025,000
-
HealthCare.gov enrollment totals higher this Sunday and Monday than all of October
-
Noble Life Sciences Inc. Receives Maryland TEDCO Award For Development Of Ex Vivo And In Vivo Assays For Anti-Metastatic Drug Development
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
BHI's vision is to transform the Central Maryland region into a leading global bio-health entrepreneurial and commercialization hub. Learn more »
BHI in the News
Prev
Next
AstraZeneca (AZ) has strengthened its research team by appointing leading academic Dr Yong-Jun Liu as head of research at its …
Montgomery County Executive Ike Leggett returned recently from a 10-day, 4-city trip to China aimed at advancing Chinese jobs and …
The University of Maryland on Wednesday announced the appointment of Thomas R. Fuerst, Ph.D., as the new director of the …
Christy Wyskiel is the new senior adviser to the president for enterprise development at Johns Hopkins University. Wyskiel has previously worked as …
MedImmune, the global biologics research and development arm of AstraZeneca, has acquired Spirogen, a privately-held biotech company focused on antibody-drug …
Biomedical Innovation Funding Forum
 |
American Society of Gene & Cell Therapy 17th Annual Meeting
 |
BioHealth Regional News |
BioHealth Job Opportunities
|
|
Home | About Us | News | Events | Disclaimer
Copyright © BioHealth Innovation 2012 - All Rights Reserved.